Verition Fund Management
SYRS

Verition Fund Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Verition Fund Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,320
Closed -$22K – 2632
2022
Q2 		$22K Buy
+2,320
New +$22K ﹤0.01% 2123